Avecho Biotechnology secures $19m+ deal with Sandoz for CBD insomnia treatment in Australia

Avecho Biotechnology Limited has entered an exclusive 10-year development and licensing agreement with Sandoz Group AG to commercialise a cannabidiol (CBD) capsule for insomnia in Australia. The deal is set to reshape the over-the-counter (OTC) CBD insomnia treatment landscape, as industry forecasts predict the Australian market for registered OTC CBD products will surpass US$125 million […